Status:

COMPLETED

An Open-label Study to Evaluate Contraceptive Efficacy and Safety of the Transdermal Contraceptive System of Norelgestromine and Ethinyl Estradiol

Lead Sponsor:

Janssen-Cilag Farmaceutica Ltda.

Conditions:

Contraception

Eligibility:

FEMALE

21-45 years

Phase:

PHASE4

Brief Summary

The purpose of this study is to evaluate the contraceptive efficacy, safety, cycle control, compliance, and subject satisfaction of the transdermal contraceptive system, norelgestromine and ethinyl es...

Detailed Description

A multicenter, open label, descriptive study. Five hundred requiring contraception will receive the weekly transdermal contraceptive patch for 6 cycles. At the baseline and after the 1st, 3rd and 6th ...

Eligibility Criteria

Inclusion

  • Healthy adult females who meet the following selection criteria: Have regular menses occuring every 25-35 days
  • Acceptable body mass (\< 30) and the weight is \< 90 kg
  • Has completed her last term pregnancy at least 4 months prior to study admission, is not lactating and has at least one normal menstrual period since her last pregnancy and not breast feeding
  • Has a sitting blood pressure systolic \< 140 mm/Hg and diastolic \< 90 mm/Hg.

Exclusion

  • Has not received a DepoProvera injection or any other depot hormone injection within six months prior to the screening visit
  • Has not used / or in current use of barbiturates, antiepileptics, rifampin, griseofulvin, Hypericum perforatum, or other hepatic enzyme-inducing drugs within 30 days prior to the pre-study visit
  • Has not a uncontrolled disorder
  • No women over the age 35 who smoke.

Key Trial Info

Start Date :

February 1 2003

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2004

Estimated Enrollment :

580 Patients enrolled

Trial Details

Trial ID

NCT00307632

Start Date

February 1 2003

End Date

December 1 2004

Last Update

May 15 2014

Active Locations (12)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (12 locations)

1

Belo Horizonte, Brazil

2

Botucatu, Brazil

3

Brasília, Brazil

4

Curitiba, Brazil